Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Disease
100%
Cell Proliferation
100%
Opiate
100%
Growth Factor
100%
Growth Factor Receptor
100%
Naltrexone
44%
Receptor
33%
Autoimmune Disease
22%
Malignant Neoplasm
11%
Drug Megadose
11%
Homeostasis
11%
Low Drug Dose
11%
Phosphotransferase
11%
Cell Cycle
11%
Public Health
11%
Maturity Onset Diabetes of the Young
11%
Enkephalin
11%
Opioid Peptide
11%
Endorphin
11%
Opiate Antagonist
11%
Receptor Expression
11%
Biological Therapy
11%
Neutralizing Antibody
11%
Cancer Treatment
11%
Wound Closure
11%
Proliferating Cell Nuclear Antigen
11%
Dry Eye
11%
Corneal Abrasion
11%
Epithelization
11%
Multiple Sclerosis
11%
Keyphrases
Cell Proliferation
100%
Opioid Growth Factor
100%
Opioid Growth Factor Receptor (OGFr)
100%
Naltrexone
57%
Homeostasis
14%
Clinical Setting
14%
Genetic Manipulation
14%
High Dose
14%
Diabetic Rats
14%
Disease Treatment
14%
Receptor Expression
14%
Opioid Antagonist
14%
Type 2 Diabetes Mellitus (T2DM)
14%
Enkephalin
14%
Cyclin
14%
Autoimmune Disease
14%
Multiple Sclerosis
14%
Continuous Exposure
14%
Kinase Cascade
14%
Human Health
14%
Inhibitory Pathways
14%
Cancer Treatment
14%
Crohn's
14%
Ultra-low Dose
14%
Antibody Neutralization
14%
Full-thickness Wound
14%
Wound Closure
14%
Autoimmune Disease Treatment
14%
Pharmacological Approaches
14%
Endogenous Opioid Peptides
14%
Corneal Abrasion
14%
Dry Eye
14%
Intermittent Exposure
14%
Biological Therapy
14%
Molecular Approaches
14%
Re-epithelialization
14%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Growth Factor
100%
Growth Factor Receptor
100%
Opiate
100%
Receptor
44%
Naltrexone
44%
Malignant Neoplasm
22%
Autoimmune Disease
22%
Phosphotransferase
11%
Non Insulin Dependent Diabetes Mellitus
11%
Cycline
11%
Opioid Antagonist
11%
Wound
11%
Enkephalin
11%
Endorphin
11%
Opiate Peptide
11%
Neutralizing Antibody
11%
Dry Eye
11%
Multiple Sclerosis
11%
Neuroscience
Growth Factor
100%
Opiate
100%
Cell Proliferation
100%
Growth Factor Receptor
100%
Naltrexone
44%
Eicosanoid Receptor
33%
Autoimmune Disease
22%
Kinase
11%
Cell Cycle
11%
Opioid Antagonist
11%
Proliferating Cell Nuclear Antigen
11%
Opioid Peptide
11%
Enkephalin
11%
Endorphin
11%
Receptor Expression
11%
Neutralizing Antibody
11%
Multiple Sclerosis
11%
Corneal Abrasion
11%
Keratoconjunctivitis Sicca
11%